Example: Heart Attack

Clinical Trials on Lupus Erythematosus, Cutaneous

Total 58 results

NCT02927457

Completed

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus Subjects

Conditions: Lupus Erythematosus, Cutaneous
NCT04493541

Recruiting

A Study to Assess the Safety and Drug Levels of BMS-986256 in Participants With Active Cutaneous Lupus Erythematosus

Conditions: Lupus Erythematosus, Cutaneous
NCT01407679

Terminated

Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus

Conditions: Lupus Erythematosus, Cutaneous
NCT01352988

Completed

Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus

Conditions: Lupus Erythematosus, Cutaneous
NCT01702740

Completed

A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus

Conditions: Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic
NCT00523588

Completed

Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser

Conditions: Cutaneous Lupus Erythematosus
NCT01470313

Terminated

A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus

Conditions: Cutaneous Lupus Erythematosus
NCT00420121

Unknown status

European Society of Cutaneous Lupus Erythematosus (EUSCLE)

Conditions: Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic
NCT04647708

Recruiting

Study of M5049 in Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE) Participants

Conditions: Systemic Lupus Erythematosus; Cutaneous Lupus Erythematosus
NCT03134222

Completed

Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)

Conditions: Cutaneous Lupus Erythematosus
NCT01841619

Completed

IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus

Conditions: Cutaneous Lupus Erythematosus
NCT00222183

Withdrawn

Cutaneous Lupus Erythematosus and Elidel

Conditions: Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid
NCT01510067

Recruiting

Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus

Conditions: Cutaneous Lupus Erythematosus
NCT00317681

Completed

Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)

Conditions: Cutaneous Lupus Erythematosus
NCT01629784

Completed

Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus

Conditions: Cutaneous Lupus Erythematosus
NCT01146444

Completed

Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE)

Conditions: Cutaneous Lupus Erythematosus
NCT02847598

Completed

Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)

Conditions: Systemic Lupus Erythematosus; Active Cutaneous Lupus Erythematosus
NCT01294774

Completed

Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus

Conditions: Subacute Cutaneous Lupus Erythematosus
NCT01300208

Completed

To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus

Conditions: Cutaneous Lupus Erythematosus
NCT00633945

Completed

Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)

Conditions: Cutaneous Lupus Erythematosus (CLE)
NCT04707924

Not yet recruiting

Efficacy of Fractional Er:YAG Laser in Lupus Erythematosus Scars

Conditions: Lupus Erythematosus, Cutaneous
NCT01551069

Completed

Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion

Conditions: Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
NCT02034344

Completed

A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers

Conditions: Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Lupus Erythematosus, Discoid; Healthy
NCT01498406

Terminated

Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus

Conditions: Cutaneous Lupus Erythematosus
NCT03260166

Unknown status

Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus Erythematosus

Conditions: Cutaneous Lupus Erythematosus; Systemic Lupus Erythematosus Rash